Thinking about what to do with Amrize stock? You are not alone. Investors have been wrestling with that same question lately, especially as Amrize’s share price has shown a few twists and turns. After ...

AngioDynamics remains a Buy, trading at a steep discount to peers despite double-digit MedTech growth and improving margins. Click to read why ANGO is a Buy.

Investing.com -- Kepler Capital has upgraded Thales to Buy from Hold, lifting its target price to €315 from €240, citing strong earnings visibility and a valuation discount relative to peers despite ...

Kinross Gold is a strong buy amid soaring gold prices, record profits, low costs, and a valuation gap. Click here to find out why I rate KGC a Strong Buy.

Shareholders of EFCIL (I) Limited (EFCIL) have approved a contentious merger with its subsidiary Whitehills Interior Limited (WIL), despite serious red flags identified in an analysis by Stakeholders ...

Gold is considered a safe-haven investment during times of turmoil and has held its value in three of the last four recessions. We have seen the price of gold climb 41 per cent over the past 12 months ...